Table 2 Administration of S-1

From: Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer

 

Arm A ( n =50)

Arm B ( n =51)

 

No.

%

No.

%

Patients following planned schedule and dose

20

40.0

15

29.4

Patients in whom administration was halted due to adverse events

11

22.0

15

29.4

Patients with dose-reduction

7

14.0

6

11.8

Patients with delayed courses

14

28.0

19

37.3

Back to article page